Results of immunohistochemistry status of HER2 expression surface epithelial ovarian cancer
- VernacularTitle:Өндгөвчийн гадаргуугийн хучуур эсийн хавдрын үед HER2-ын илэрхийллийг дархангистохимээр тодорхойлсон дүн
- Author:
Odonzul Ts
1
;
Galtsog L
1
;
Avirmed D
2
;
Erdenetsogt D
3
Author Information
1. Ach Medical University
2. National Cancer Center
3. Mongolian National University of Medical Science
- Publication Type:Journal Article
- Keywords:
EOC;
epithelial ovarian cancer;
HER2;
IHC;
Immunohistochemistry
- From:Mongolian Medical Sciences
2018;183(1):9-15
- CountryMongolia
- Language:Mongolian
-
Abstract:
Introduction :The HER2 (Human epidermal receptor 2) proto-oncogene encodes a transmembrane receptor protein involved in the development and progression of the majority of cancers. Prior studies have shown that HER2 oncogene is overexpressed in approximately 15–30% of ovarian carcinomas. However findings regarding the overexpression and prognosis are still conflicting.
Goal:To determine the histomorphological structure of ovarian tumor and perform immunohistochemical analysis of HER2 in tumor tissues
Materials and Methods:A total of epithelial ovarian cancer paraffin-embedded tissue blocks 11collected. The hematoxylin and eosin stained histopathology slides of each of the cases were reviewed to confirm the original diagnosis, and to assess the histological grade of the neoplasm. Our study was performed on 11 ovarian epithelial cancer tissues obtained at the time of first surgery. The staining procedure for HER2 overexpression was performed using a monoclonal antibody.
Results:The positive expression rate of HER2 in this study was 81.8%. Significant association was not found between HER2 expression International Federation of Gynecologists and Obstetrics (FIGO) stage p-values of 0.196, grading 0.642 and histological subtypes. However, there were more cases of advanced-stage disease (III/IV) with HER-2 expression than early-stage EOC (I/II). HER2 positive tumor were grades 1, 2 and 3 respectively. A higher proportion of serous ovarian neoplasm and adenocarcinoma NOS was also observed to be HER2 positive.
Conclusion:HER2 expression was observed to increase with advanced stages of cancer and was more commonly seen in serous rather than in adenocarcinoma NOS.
- Full text:2018-183(1)-9-15.pdf
